Bottom line
IXJ vs HCPIX: the short answer
IXJ (iShares Global Healthcare ETF) and HCPIX (Health Care Ultrasector Profund) share a meaningful slice of their top holdings — about 72% by weight.
IXJ is cheaper at 0.38% vs 1.76% — a difference of $138 a year per $10,000 invested.
Over five years, HCPIX returned +6.4% a year vs +6.4% for IXJ (reporting dates differ).
Updated Nov 19, 2026
IXJ vs HCPIX side by side
| IXJ | HCPIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | ProShares |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.38% | 1.76% |
| Annual cost per $10k | $38 | $176 |
| 10-yr cost on $10k (prospectus) | $480 | $2,073 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +14.9% | −1.4% |
| 5-yr return (annualized) | +6.4% | +6.4% |
| 10-yr return (annualized) | +8.2% | +9.2% |
| Best quarter | +13.6% | +22.0% |
| Worst quarter | −11.8% | −21.0% |
| Net assets (fund) | $3.8B | $12.1M |
| Number of holdings | 124 | 69 |
| Portfolio turnover | 2% | 99% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IXJ | HCPIX | Difference |
|---|---|---|---|
| 2024 | +0.6% | −1.4% | +2.0% |
| 2023 | +3.5% | −1.3% | +4.8% |
| 2022 | −4.7% | −10.6% | +5.9% |
| 2021 | +19.5% | +33.9% | −14.4% |
| 2020 | +12.5% | +16.9% | −4.4% |
| 2019 | +23.4% | +28.4% | −5.1% |
| 2018 | +2.9% | +5.0% | −2.1% |
| 2017 | +20.3% | +32.2% | −11.8% |
| 2016 | −6.2% | −6.5% | +0.3% |
| 2015 | +5.9% | +6.4% | −0.5% |
Source: Fund prospectus bar charts
Holdings overlap
19 of IXJ's top 25 holdings also appear in HCPIX's top 25.
| Holding | IXJ | HCPIX |
|---|---|---|
| Eli Lilly And Company | 10.93% | 11.83% |
| Johnson & Johnson | 7.04% | 8.03% |
| Abbvie Inc. | 5.12% | 5.77% |
| Unitedhealth Group Incorporated | 4.40% | 4.90% |
| Merck & Co., Inc. | 4.12% | 4.19% |
| Amgen Inc. | 2.54% | 2.71% |
| Thermo Fisher Scientific Incorporated | 2.42% | 2.78% |
| Abbott Laboratories | 2.05% | 2.40% |
| Gilead Sciences, Inc. | 2.04% | 2.10% |
| Intuitive Surgical, Inc. | 1.83% | 1.63% |
| Pfizer Inc. | 1.78% | 1.86% |
| Cvs Health Corporation | 1.71% | 1.73% |
| Vertex Pharmaceuticals Incorporated | 1.64% | 1.57% |
| Danaher Corporation | 1.56% | 1.60% |
| Bristol-myers Squibb Company | 1.53% | 1.74% |
Source: SEC Form N-PORT
IXJ top 10
- Eli Lilly And Company — 10.93%
- Johnson & Johnson — 7.04%
- Abbvie Inc. — 5.12%
- Unitedhealth Group Incorporated — 4.40%
- Merck & Co., Inc. — 4.12%
- Astrazeneca Plc — 3.76%
- Roche Holding AG — 3.75%
- Novartis AG — 3.71%
- Amgen Inc. — 2.54%
- Thermo Fisher Scientific Incorporated — 2.42%
HCPIX top 10
- Eli Lilly & Company — 11.83%
- Johnson & Johnson — 8.03%
- N/a — 6.45%
- Abbvie Inc — 5.77%
- N/a — 4.97%
- Unitedhealth Group Inc — 4.90%
- Merck & Company Inc — 4.19%
- N/a — 3.96%
- N/a — 3.96%
- N/a — 3.11%
FAQ
What is the difference between IXJ and HCPIX?
Which is cheaper, IXJ or HCPIX?
Should I own both IXJ and HCPIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.